News

Researchers have used single-cell analysis technology to provide new insight into the Salmonella infection process.

Researches have identifed a component, found in areca nuts, to have anticancer properties.

Researchers develop new model for the study early-stage Alzheimer's, focusing on a particular protein.

Novel drug delivery method could aid in elimination of malaria and treatment of many other diseases.

Single-cell sequencing gives new insights into how genetic activity in mouse heart cells changed over time.

The agreement gives Mylan exclusive rights to sell Mabion’s biosimilar of Mabthera/Rituximab (Mabion CD20) in all EU countries and non EU Balkan states.

The team found thousands of new genes linked to specific diseases, including autoimmune diseases such as rheumatoid arthritis, type 1 diabetes and Crohn’s disease that are currently incurable and notoriously difficult to treat or prevent.

The 300mmol expansion in 2016 followed by the new >1.5mol facility in 2017 will help clients to receive timely oligonucleotide drug substance to advance programs in clinical trials as planned.

The new location will work in concert with its clients and investigator sites to collect and ship drug products, clinical trial materials and biological samples.

Agreement to acquire Arsia Therapeutics marking entry into biosimilar market.